Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series Ltd: World’s leading Event Organizer
Omics International publishes 304 Open Access Articles in 13 International Journals it has 32 Upcoming Conferences and 15 Previous Conferences with 581 Conference Proceedings and 92 National symposiums so far in the field.
According to National Institute of Mental Health Anxiety disorders are the most common mental illness in the United States affecting 40 million adults in the age 18 and older, or around 18% of their population. As per world health organization around 450 million people suffer from a mental or behavioural disorder.
Anxiety disorders can develop from a wide renge of risk factors, that includes genetics, brain chemistry, life events , and personality. Anxiety disorders can be treated easily, but still about one-third of of the people suffering from anxiety disorder receive treatment. These medications can be very effective, but they shouldn’t be thought of as a cure. Anxiety medicine can provide temporary relief, but it doesn’t treat the underlying cause of the anxiety disorder. After you stop taking the drug, the anxiety symptoms often return in full force. Anxiety Medicine can relieve some of the symptoms of anxiety, but it doesn’t cure the underlying problem and is generally not a long-term solution. Anxiety medication can cause a broad range of side effects. Some medicines for anxiety treatment are very addictive in nature . Comparing the drug benefits against the drawbacks can predict the importance of drug. Some other therapies and lifestyle changes can help in treating such problems. Many different types of medications are used in the treatment of anxiety disorders, that includes anti-anxiety drugs such as benzodiazepines, antidepressants and beta-blockers.
It has been seen that antidepressants are widely used to treat and prevent a variety of anxiety disorders. For Immediate relief Benzodiazepines are the most prominent of anti-anxiety drugs. Buspar is another drug for treating anxiety. A good advantage is that it has fewer side effects than the benzodiazepines and is not associated with dependence. Tranquilizers, another variety of anti-anxiety drugs, are medications that relieve anxiety by slowing down the central nervous system. It has been reported that the drug has its own side effects and may not always be as effective when a person has taken benzodiazepines in the past.
OMICS International through its Open access initiatives is committed to make genuine and reliable contributions to the scientific community by publishing research work and conference paper related to such disorders. It is known that OMICS Group hosts over 700 edge peer reviewed Open Access Journals which contains over 75000 eminent personalities, reputed scientists as editorial board members. Omics International organizes over more than 1000 Global Events annually with support from 1000 more scientific Societies. Its publishing group journals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board that ensure a quality and quick review process checker.
As per the "Economic Burden of Anxiety Disorders," a study consigned by ADAA, the cost to United States for Anxiety disorders is more than $ 42 billion a year, nearly one-third of the country's $ 148 billion total mental health bill. NARSAD Grant provides $30,000 per year on research in brain and behavioural disorders such as schizophrenia, anxiety disorders and child or adolescent mental illnesses.
This page will be updated regularly.
This page was last updated on 11th Sep, 2015
1-702-508-5200 Ext:8031, 8041
1-702-508-5200 Ext:8045, 8047
Immunology & Microbiology Conferences
Nursing and Healthcare Conferences
Clinical and Biochemistry Conferences
1-702-508-5200 Ext:8031, 8037
Material Science Conferences
Genetics & Mol Biology Conferences
Media Partners | Advertising